SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Income Taxes
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Deferred Income Taxes of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for the quarter ending 2026-06-30 was $0.00.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for the quarter ending 2026-03-31 was $431.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for the quarter ending 2025-06-30 was -$93.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for the quarter ending 2025-03-31 was -$188.00K, a 193.53% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for fiscal 2026 was $231.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for fiscal 2025 was -$357.00K, a 427.52% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for fiscal 2024 was $109.00K, a 194.59% increase from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for fiscal 2023 was $37.00K, a 95.54% decline from fiscal 2022.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $431.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $231.00K 10-K · filed 2026-06-16 | ||
| 2025-12-31 | -$200.00K 10-Q · filed 2026-02-10 | |||
| 2025-06-30 | -$93.00K 10-Q · filed 2026-08-06 | -$281.00K derived: sum of 2 quarters · filed 2026-08-06 | -$262.00K derived: sum of 3 quarters · filed 2026-08-06 | -$328.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | -$169.00K derived: sum of 2 quarters · filed 2026-06-16 | -$235.00K derived: sum of 3 quarters · filed 2026-06-16 | -$357.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | -$47.00K derived: sum of 2 quarters · filed 2026-02-10 | -$169.00K 10-Q · filed 2026-02-10 | $32.00K derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | -$66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$188.00K 10-Q · filed 2024-11-07 | $13.00K derived: sum of 3 quarters · filed 2025-08-07 | $65.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | -$122.00K 10-Q · filed 2025-08-07 | $79.00K derived: sum of 2 quarters · filed 2025-08-07 | $131.00K derived: sum of 3 quarters · filed 2025-08-07 | $77.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $253.00K derived: sum of 2 quarters · filed 2025-06-17 | $199.00K derived: sum of 3 quarters · filed 2025-06-17 | $109.00K 10-K · filed 2025-06-17 |
| 2023-12-31 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | -$2.00K derived: sum of 2 quarters · filed 2025-02-05 | -$92.00K 10-Q · filed 2025-02-05 | -$298.00K derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-09-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$144.00K 10-Q · filed 2024-11-07 | -$350.00K derived: sum of 3 quarters · filed 2024-11-07 | -$246.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$90.00K 10-Q · filed 2024-08-08 | -$296.00K derived: sum of 2 quarters · filed 2024-08-08 | -$192.00K derived: sum of 3 quarters · filed 2024-08-08 | -$93.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | -$102.00K derived: sum of 2 quarters · filed 2024-06-17 | -$3.00K derived: sum of 3 quarters · filed 2024-06-17 | $37.00K 10-K · filed 2024-06-17 |
| 2022-12-31 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $203.00K derived: sum of 2 quarters · filed 2023-02-14 | $243.00K 10-Q · filed 2023-02-14 | $1.07M derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-09-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $139.00K 10-Q · filed 2022-11-14 | $968.00K derived: sum of 3 quarters · filed 2023-06-21 | $968.00K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-06-30 | $40.00K 10-Q · filed 2022-08-11 | $869.00K derived: sum of 2 quarters · filed 2023-06-21 | $869.00K derived: sum of 3 quarters · filed 2023-06-21 | $869.00K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-03-31 | $829.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | $829.00K derived: sum of 2 quarters · filed 2023-06-21 | $829.00K derived: sum of 3 quarters · filed 2023-06-21 | $829.00K 10-K · filed 2023-06-21 |
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $0.00 derived: sum of 2 quarters · filed 2023-02-14 | $0.00 10-Q · filed 2023-02-14 | |
| 2021-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |